Short- versus Long-Sarafotoxins: Two Structurally Related Snake Toxins with Very Different in vivo Haemodynamic Effects

• Published in: PloS one Vol. 10; no. 7; p. e0132864
• Main Authors: Mahjoub, Yazine, Malaquin, Stéphanie, Mourier, Gilles, Lorne, Emmanuel, Abou Arab, Osama, Massy, Ziad A, Dupont, Hervé, Ducancel, Frédéric
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 15.07.2015; Public Library of Science (PLoS)
• Subjects: Affinity; Amino acids; Animals; Atractaspis; Biocompatibility; C-Terminus; Cardiac output; Catheters; Echocardiography, Doppler; Electrocardiography; Endothelin receptors; Endothelins; Heart; Heart diseases; Heart Rate - drug effects; Hemodynamics - drug effects; Homology; In vivo methods and tests; Intravenous administration; Laboratory animals; Lung - drug effects; Male; Next-generation sequencing; Peptides; Pharmacology; Pressure; Rats; Rats, Wistar; Receptors; Reproducibility of Results; Respiratory tract; Rodents; Structural Homology, Protein; Studies; Toxicity; Toxins; Veins & arteries; Venom; Ventilation; Ventricle; Ventricular Function - drug effects; Viper Venoms - chemistry; Viper Venoms - pharmacology
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0132864

Sarafotoxin-m (24 amino acids) from the venom of Atractaspis microlepidota microlepidota was the first long-sarafotoxin to be identified, while sarafotoxin-b (21 aa) is a short-sarafotoxin from Atractaspis engaddensis. Despite the presence of three additional C-terminus residues in sarafotoxin-m, these two peptides display a high sequence homology and share similar three-dimensional structures. However, unlike sarafotoxin-b, sarafotoxin-m shows a very low in vitro affinity for endothelin receptors, but still has a very high in vivo toxicity in mammals, similar to that of sarafotoxin-b. We have previously demonstrated, in vitro, the crucial role of the C-terminus extension in terms of pharmacological profiles and receptor affinities of long- versus short-sarafotoxins. One possible hypothesis to explain the high in vivo toxicity of sarafotoxin-m could be that its C-terminus extension is processed in vivo, resulting in short-like sarafotoxin. To address this possibility, we investigated, in the present study, the in vivo cardiovascular effects of sarafotoxin-b, sarafotoxin-m and sarafotoxin-m-Cter (sarafotoxin-m without the C -terminus extension). Male Wistar rats were anaesthetised and mechanically ventilated. Invasive haemodynamic measurements and echocardiographic measurements of left and right ventricular function were performed. The rats were divided into four groups that respectively received intravenous injections of: saline, sarafotoxin-b (one LD50), sarafotoxin-m (one LD50) or sarafotoxin-m-Cter (one LD50). All measurements were performed at baseline, at 1 minute (+1) and at 6 minutes (+6) after injection. Sarafotoxin-b and sarafotoxin-m-Cter decreased cardiac output and impaired left ventricle systolic and diastolic function, whilst sarafotoxin-m decreased cardiac output, increased airway pressures and led to acute right ventricular dilatation associated with a decreased tricuspid annulus peak systolic velocity. Sarafotoxin-b and sarafotoxin-m-Cter appear to exert toxic effects via impairment of left ventricular function, whilst sarafotoxin-m increases airway pressures and impairs right ventricular function. These results do not support the hypothesis of an in vivo processing of long sarafotoxins.